Stoma/Ostomy Care Market size is slated to gain remarkable traction over 2021-2027, on account of the escalating sales of stoma and ostomy care products through online channels, coupled with the rising prevalence of chronic diseases including colorectal cancer (CRC), inflammatory bowel condition, and Crohn’s disease, especially in the U.S. In 2021, Better Health secured $3.5 million in a seed funding round to boost the sales of colostomy bags and other medical supplies for chronic conditions via the e-Commerce platform.
An ostomy is a surgical procedure that facilitates the removal of waste materials by creating an artificial opening in the abdomen of the patients. Depending on the ostomy types, namely colostomy, ileostomy, and urostomy, an organ is connected to the opening of the abdomen, also known as stoma, for the elimination of body wastes.
Rapid technology advancements in ostomy care products, along with the growth of medical tourism due to the varying costs of bowel cancer and other disease treatment, are the key trends stimulating the overall market expansion. For example, OstomyCure AS has deployed the latest 3D technology in manufacturing its TIES III Solution, designed to help minimize skin complications and promote reliable tissue ingrowth for ostomy patients.
Despite the favorable growth environments, a range of complications associated with the use of stoma/ostomy care products including skin irritation, leakage, and retraction may create hindrance to the steady industry growth over the coming years. While several complications from stomas are considered to be minor, other side effects such as necrosis and dehydration may often result in medical emergencies.
Considering the system, the two-piece segment is projected to hold a considerable share by 2027, which is attributable to the shifting preference of ostomates from one-piece to two-piece ostomy system, as the flanges or wafers in this system can remain intact for 2-4 days, as well as owing to the seamless removal of the ostomy bags. For example, the New Image 2-piece ostomy system introduced by Hollister has been gaining widespread adoption across Canada, given the product’s capability to ensure effective deodorization and release of gas, among other usage advantages.
On the regional front, the North America market is anticipated to depict a high growth rate through 2027, led by the accelerating colorectal cancer-related deaths, alongside the high prevalence of CRC disease among the increasing geriatric population base in the U.S. According to the American Cancer Society’s estimates, over 104,270 people are likely to be diagnosed with colon cancer in the country in 2021.
The global stoma/ostomy care market is bolstered by the presence of prominent companies such as Smith & Nephew, 3M, Perma-Type, Cymed, Flexicare Medical, Bao-Health, Welland Medical, Marlen International, Nu-Hope, Alcare, B. Braun, Hollister Incorporated, and Coloplast, among others. These firms are incorporating various strategies such as new product launches and M&A, and more to amass hefty profits and enhance their product portfolio.
For instance, in October 2020, Tata Elxsi announced the opening of a new GEC (Global Engineering Center) in Pune, in collaboration with B. Braun’s subsidiary, Aesculap AG, with an objective to strengthen the supply of medical products, including stoma and colostomy care, in Europe.
In the wake of the COVID-19 pandemic, there has been a sustained reduction in the rate of diagnosis and treatment of patients with colorectal cancer in hospitals. The coronavirus-related treatment is being highly prioritized among CRC patients who acquired the virus, as long as they do not present any surgical emergency. This significant delay in the CRC therapy during the pandemic may pose adverse impacts on the growth of the industry.
However, as per a survey conducted in 36 hospitals across the UK and Ireland, 97.1% of the hospitals continued their patient management through telephone triage in order to avoid face-to-face consultation and limit exposure to the virus, while ensuring continuity in their businesses. This significant modification in the treatment of CRC patients, alongside the gradual ease of strict lockdowns, is expected to assert positive affluence in the delivery of stoma care procedures over the coming years.
Market, by Surgery, 2013-2024 (USD Million)
Market, by System, 2013-2024 (USD Million)
Market, by Usability, 2013-2024 (USD Million)
Market, by End-use, 2013-2024 (USD Million)
The above information is provided for the following regions and countries: